VILINBIOPharmaceuticals
Vilin Bio Med Ltd — Cash Flow Statement
₹38.10
+0.00%
Vilin Bio Med Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | -5.30 Cr | -1.69 Cr | 0.21 Cr | -1.00 Cr |
| Issuance Of Debt | 0.22 Cr | 0.29 Cr | 0.07 Cr | 1.02 Cr |
| Issuance Of Capital Stock | 12.00 Cr | 2.04 Cr | — | — |
| End Cash Position | 6.05 Cr | 0.03 Cr | 0.04 Cr | 0.05 Cr |
| Beginning Cash Position | 0.03 Cr | 0.04 Cr | 0.05 Cr | 0.07 Cr |
| Changes In Cash | 6.01 Cr | -45000.00 | -76000.00 | -0.02 Cr |
| Financing Cash Flow | 10.99 Cr | 1.68 Cr | -0.22 Cr | 0.98 Cr |
| Net Other Financing Charges | -1.23 Cr | -0.58 Cr | — | — |
| Net Common Stock Issuance | 12.00 Cr | 2.04 Cr | — | — |
| Common Stock Issuance | 12.00 Cr | 2.04 Cr | — | — |
| Net Issuance Payments Of Debt | 0.22 Cr | 0.23 Cr | -0.22 Cr | 0.98 Cr |
| Net Long Term Debt Issuance | 0.22 Cr | 0.23 Cr | -0.28 Cr | 1.02 Cr |
| Long Term Debt Issuance | 0.22 Cr | 0.29 Cr | — | 1.02 Cr |
| Investing Cash Flow | 0.32 Cr | -0.03 Cr | 0.00 | 0.00 |
| Net Other Investing Changes | -26000.00 | — | — | — |
| Interest Received Cfi | 0.32 Cr | — | — | — |
| Net PPE Purchase And Sale | 13000.00 | -0.03 Cr | 0.00 | 0.00 |
| Sale Of PPE | 13000.00 | — | — | — |
| Operating Cash Flow | -5.30 Cr | -1.66 Cr | 0.21 Cr | -1.00 Cr |
| Taxes Refund Paid | -0.05 Cr | -0.54 Cr | -0.01 Cr | -0.04 Cr |
| Interest Paid Cfo | -0.32 Cr | — | — | — |
| Change In Working Capital | -6.07 Cr | -3.07 Cr | -0.05 Cr | -1.38 Cr |
| Change In Other Current Liabilities | 1.98 Cr | 0.15 Cr | 0.05 Cr | -0.16 Cr |
| Change In Other Current Assets | -1.00 Cr | -3.49 Cr | 0.03 Cr | — |
| Change In Payable | 0.76 Cr | 0.55 Cr | -0.18 Cr | -1.04 Cr |
| Change In Inventory | -3.59 Cr | 1.41 Cr | -0.22 Cr | 0.05 Cr |
| Change In Receivables | -4.25 Cr | -2.19 Cr | 0.29 Cr | -0.21 Cr |
| Other Non Cash Items | 0.79 Cr | — | — | — |
| Depreciation And Amortization | 0.13 Cr | 0.17 Cr | 0.22 Cr | 0.26 Cr |
| Depreciation | 0.13 Cr | 0.17 Cr | 0.22 Cr | 0.26 Cr |
| Net Income From Continuing Operations | 0.23 Cr | 1.78 Cr | 0.04 Cr | 0.16 Cr |
| Repayment Of Debt | — | -0.07 Cr | -0.28 Cr | -0.03 Cr |
| Capital Expenditure | — | -0.03 Cr | — | — |
| Long Term Debt Payments | — | -0.07 Cr | -0.28 Cr | — |
| Purchase Of PPE | — | -0.03 Cr | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | 1000.00 | — |
| Net Short Term Debt Issuance | — | — | 0.07 Cr | -0.03 Cr |
| Short Term Debt Issuance | — | — | 0.07 Cr | — |
| Net Investment Purchase And Sale | — | — | 0.00 | 0.00 |
| Purchase Of Investment | — | — | 0.00 | 0.00 |
| Short Term Debt Payments | — | — | — | -0.03 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vilin Bio Med Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.